Suppression of experimental allergic encephalomyelitis by chemically modified encephalitogen.
D000818:Animals; D000941:Antigens; D001666:Binding Sites, Antibody; D001933:Brain Stem / Q000473:pathology; D002531:Cerebellum / Q000473:pathology; D004591:Electrophoresis, Polyacrylamide Gel; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000473:pathology / Q000517:prevention & control*; D005561:Formates; D006168:Guinea Pigs; D009186:Myelin Sheath / Q000276:immunology*; D009419:Nerve Tissue Proteins; D009578:Nitrobenzenes; D009596:Nitrophenols; D013053:Spectrophotometry; D013116:Spinal Cord / Q000473:pathology; D013434:Sulfenic Acids; D014364:Tryptophan
D000941:Antigens; D005561:Formates; D009419:Nerve Tissue Proteins; D009578:Nitrobenzenes; D009596:Nitrophenols; D013434:Sulfenic Acids; D014364:Tryptophan